| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands.
|
Neuromuscul Disord
|
2004
|
2.85
|
|
2
|
Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations.
|
Arthritis Rheum
|
2005
|
1.89
|
|
3
|
Low serum levels of vitamin D in idiopathic inflammatory myopathies.
|
Ann Rheum Dis
|
2012
|
1.59
|
|
4
|
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.
|
J Clin Invest
|
2015
|
1.51
|
|
5
|
Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running.
|
J Physiol
|
2004
|
1.49
|
|
6
|
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.
|
Scand J Rheumatol
|
2002
|
1.35
|
|
7
|
A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies.
|
Arthritis Rheum
|
2007
|
1.31
|
|
8
|
Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.
|
Arthritis Res Ther
|
2009
|
1.29
|
|
9
|
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.
|
Arthritis Rheum
|
2007
|
1.28
|
|
10
|
Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
|
Arthritis Rheum
|
2003
|
1.20
|
|
11
|
Pathogenesis, classification and treatment of inflammatory myopathies.
|
Nat Rev Rheumatol
|
2011
|
1.18
|
|
12
|
Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology.
|
Arthritis Rheum
|
2008
|
1.18
|
|
13
|
Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
|
Ann Neurol
|
2013
|
1.16
|
|
14
|
T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
|
J Immunol
|
2009
|
1.15
|
|
15
|
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.
|
Arthritis Rheum
|
2013
|
1.12
|
|
16
|
Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.
|
Arthritis Res Ther
|
2012
|
1.11
|
|
17
|
Experiencing virtual patients in clinical learning: a phenomenological study.
|
Adv Health Sci Educ Theory Pract
|
2011
|
1.10
|
|
18
|
Pulmonary complications of polymyositis and dermatomyositis.
|
Semin Respir Crit Care Med
|
2007
|
1.10
|
|
19
|
Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositis.
|
Arthritis Rheum
|
2007
|
1.08
|
|
20
|
Reliability and validity of the myositis disease activity assessment tool.
|
Arthritis Rheum
|
2008
|
1.07
|
|
21
|
Interstitial lung disease in polymyositis and dermatomyositis.
|
Curr Opin Rheumatol
|
2005
|
1.07
|
|
22
|
Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids.
|
Arthritis Rheum
|
2004
|
1.06
|
|
23
|
Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositis.
|
Arthritis Rheum
|
2007
|
1.04
|
|
24
|
Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies.
|
FASEB J
|
2009
|
1.04
|
|
25
|
Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay.
|
Rheumatology (Oxford)
|
2010
|
1.04
|
|
26
|
Functional index-2: Validity and reliability of a disease-specific measure of impairment in patients with polymyositis and dermatomyositis.
|
Arthritis Rheum
|
2006
|
1.01
|
|
27
|
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
|
Medicine (Baltimore)
|
2012
|
0.99
|
|
28
|
Interstitial lung disease and idiopathic inflammatory myopathies: progress and pitfalls.
|
Curr Opin Rheumatol
|
2010
|
0.97
|
|
29
|
Expanded T cell receptor Vβ-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells.
|
Arthritis Rheum
|
2010
|
0.97
|
|
30
|
Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle.
|
Muscle Nerve
|
2009
|
0.96
|
|
31
|
Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle.
|
Curr Opin Rheumatol
|
2009
|
0.94
|
|
32
|
Exercise as a therapeutic modality in patients with idiopathic inflammatory myopathies.
|
Curr Opin Rheumatol
|
2012
|
0.94
|
|
33
|
Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis.
|
Arthritis Rheum
|
2008
|
0.94
|
|
34
|
Association of the proinflammatory haplotype (MICA5.1/TNF2/TNFa2/DRB1*03) with polymyositis and dermatomyositis.
|
Arthritis Rheum
|
2004
|
0.94
|
|
35
|
Endothelial cell activation and neovascularization are prominent in dermatomyositis.
|
J Autoimmune Dis
|
2006
|
0.93
|
|
36
|
A longitudinal, integrated, clinical, histological and mRNA profiling study of resistance exercise in myositis.
|
Mol Med
|
2010
|
0.93
|
|
37
|
Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.
|
Rheumatology (Oxford)
|
2013
|
0.92
|
|
38
|
Impaired myofibrillar function in the soleus muscle of mice with collagen-induced arthritis.
|
Arthritis Rheum
|
2009
|
0.91
|
|
39
|
Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
|
Rheumatology (Oxford)
|
2009
|
0.91
|
|
40
|
Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue.
|
Arthritis Rheum
|
2002
|
0.90
|
|
41
|
Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies.
|
Arthritis Res Ther
|
2007
|
0.90
|
|
42
|
Sporadic inclusion body myositis: pilot study on the effects of a home exercise program on muscle function, histopathology and inflammatory reaction.
|
J Rehabil Med
|
2003
|
0.90
|
|
43
|
Restricted T cell receptor BV gene usage in the lungs and muscles of patients with idiopathic inflammatory myopathies.
|
Arthritis Rheum
|
2007
|
0.89
|
|
44
|
Pathogenesis of idiopathic inflammatory myopathies.
|
Curr Rheumatol Rep
|
2006
|
0.87
|
|
45
|
TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis.
|
Ann Rheum Dis
|
2012
|
0.87
|
|
46
|
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage.
|
Arthritis Rheum
|
2011
|
0.87
|
|
47
|
Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial.
|
Arthritis Rheum
|
2007
|
0.87
|
|
48
|
Cytokines in idiopathic inflammatory myopathies.
|
Autoimmunity
|
2006
|
0.87
|
|
49
|
Serial analysis of Ro/SSA and La/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus.
|
Scand J Rheumatol
|
2002
|
0.86
|
|
50
|
Patients with polymyositis or dermatomyositis have reduced grip force and health-related quality of life in comparison with reference values: an observational study.
|
Rheumatology (Oxford)
|
2010
|
0.84
|
|
51
|
Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
|
Arthritis Rheum
|
2009
|
0.84
|
|
52
|
New insights into the benefits of exercise for muscle health in patients with idiopathic inflammatory myositis.
|
Curr Rheumatol Rep
|
2014
|
0.84
|
|
53
|
Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
|
Arthritis Rheum
|
2007
|
0.84
|
|
54
|
193rd ENMC International workshop Pathology diagnosis of idiopathic inflammatory myopathies 30 November - 2 December 2012, Naarden, The Netherlands.
|
Neuromuscul Disord
|
2013
|
0.84
|
|
55
|
Cardiovascular disease in patients with inflammatory rheumatic disease is associated with up-regulation of markers of inflammation in cardiac microvessels and cardiomyocytes.
|
Arthritis Rheum
|
2010
|
0.84
|
|
56
|
Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up.
|
Ann Rheum Dis
|
2013
|
0.83
|
|
57
|
Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositis.
|
J Autoimmun
|
2006
|
0.83
|
|
58
|
Polymyositis and dermatomyositis: pathophysiology.
|
Rheum Dis Clin North Am
|
2011
|
0.83
|
|
59
|
Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis.
|
J Rheumatol
|
2011
|
0.82
|
|
60
|
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
|
Ann Rheum Dis
|
2007
|
0.82
|
|
61
|
Improved exercise performance and increased aerobic capacity after endurance training of patients with stable polymyositis and dermatomyositis.
|
Arthritis Res Ther
|
2013
|
0.81
|
|
62
|
Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
|
Autoimmun Rev
|
2009
|
0.81
|
|
63
|
Vascular involvement in the pathogenesis of idiopathic inflammatory myopathies.
|
Autoimmunity
|
2009
|
0.81
|
|
64
|
Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
|
Ann Rheum Dis
|
2012
|
0.81
|
|
65
|
Development of the myositis activities profile--validity and reliability of a self-administered questionnaire to assess activity limitations in patients with polymyositis/dermatomyositis.
|
J Rheumatol
|
2002
|
0.81
|
|
66
|
Interrater reliability and aspects of validity of the myositis damage index.
|
Ann Rheum Dis
|
2011
|
0.81
|
|
67
|
Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review.
|
J Rheumatol
|
2012
|
0.80
|
|
68
|
Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.
|
PLoS One
|
2012
|
0.80
|
|
69
|
Proteomic profiling reveals autoimmune targets in sarcoidosis.
|
Am J Respir Crit Care Med
|
2015
|
0.80
|
|
70
|
Higher pain sensitivity and lower muscle strength in postmenonpausal women with early rheumatoid arthritis compared with age-matched healthy women--a pilot study.
|
Disabil Rehabil
|
2013
|
0.78
|
|
71
|
Idiopathic inflammatory myopathies - myositis.
|
Best Pract Res Clin Rheumatol
|
2002
|
0.78
|
|
72
|
Elevated expression of prostaglandin E2 synthetic pathway in skeletal muscle of prior polio patients.
|
J Rehabil Med
|
2014
|
0.78
|
|
73
|
Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.
|
J Rheumatol
|
2014
|
0.78
|
|
74
|
Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis.
|
Ann Rheum Dis
|
2012
|
0.77
|
|
75
|
Clinical symptoms in patients with myositis-an acquired metabolic myopathy?
|
Curr Opin Rheumatol
|
2003
|
0.77
|
|
76
|
The role of exercise in the rehabilitation of idiopathic inflammatory myopathies.
|
Curr Opin Rheumatol
|
2005
|
0.76
|
|
77
|
New possibilities to achieve increased understanding of disease mechanisms in idiopathic inflammatory myopathies.
|
Curr Opin Rheumatol
|
2002
|
0.76
|
|
78
|
CBA/J mice infected with Trypanosoma cruzi: an experimental model for inflammatory myopathies.
|
Muscle Nerve
|
2003
|
0.76
|
|
79
|
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies.
|
Arthritis Res Ther
|
2014
|
0.76
|
|
80
|
Inflammatory muscle disease: clinical presentation and assessment of patients.
|
Curr Rheumatol Rep
|
2007
|
0.76
|
|
81
|
Expression of High Mobility Group Protein B1 in Cardiac Tissue of Elderly Patients with Coronary Artery Disease with or without Inflammatory Rheumatic Disease.
|
Gerontology
|
2017
|
0.75
|
|
82
|
MICA4/HLA-DRB1*04/TNF1 haplotype is associated with mixed connective tissue disease in Swedish patients.
|
Hum Immunol
|
2003
|
0.75
|
|
83
|
Hand exercise intervention in patients with polymyositis and dermatomyositis: a pilot study.
|
Musculoskeletal Care
|
2014
|
0.75
|
|
84
|
Treatment-resistant inflammatory myopathy.
|
Best Pract Res Clin Rheumatol
|
2010
|
0.75
|
|
85
|
Recent clinical trials in idiopathic inflammatory myopathies.
|
Curr Opin Rheumatol
|
2017
|
0.75
|
|
86
|
[Temporal arteritis].
|
Lakartidningen
|
2005
|
0.75
|
|
87
|
Cardiomyopathy in murine models of systemic sclerosis.
|
Arthritis Rheumatol
|
2015
|
0.75
|
|
88
|
Effects of adalimumab treatment on endothelial cell activation markers in the skeletal muscle of patients with rheumatoid arthritis.
|
Clin Exp Rheumatol
|
2014
|
0.75
|